Literature DB >> 24290834

[Ocular manifestations in Behçet's disease].

H Zeghidi1, D Saadoun2, B Bodaghi3.   

Abstract

Uveitis is the most common ocular symptom in Behçet's disease. It is considered as a diagnostic criterion of the disease. Anterior uveitis is always non granulomatous, and sometimes associated with hypopion. Posterior involvement may include vitritis, retinal infiltrates, sheathing of retinal veins, occlusive vasculitis, and macular edema. Behçet's disease is chronic, and characterized by a spontaneously relapsing and remitting course. Male patients with younger age at onset and worse visual acuity at presentation, have higher risk of visual loss over time. The main goals in the management of patients with Behçet's disease-associated uveitis are rapid suppression of intraocular inflammation, preservation of vision, prevention of recurrences, and achievement of remission sustained after discontinuation of treatment. New therapeutic strategies such as interferon alpha and TNF alpha blockers have dramatically improved the visual prognosis of patients with intraocular inflammation related to this chronic and potentially blinding condition.
Copyright © 2013. Published by Elsevier SAS.

Entities:  

Keywords:  Anti-TNF alpha; Behçet's disease; Interferon alpha; Interféron alpha; Maladie de Behçet; Uveitis; Uvéite; Vascularite; Vasculitis

Mesh:

Year:  2013        PMID: 24290834     DOI: 10.1016/j.revmed.2013.10.011

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  4 in total

1.  Propolis modulates NOS2/arginase-1 pathway in tropomyosin-induced experimental autoimmune uveitis.

Authors:  Kahina Touri; Houda Belguendouz; Oussama Medjeber; Zineb Djeraba; Karima Lahmar; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-05-11       Impact factor: 4.473

Review 2.  Headache in Behçet's syndrome: review of literature and NYU Behçet's syndrome center experience.

Authors:  Vijay Vishwanath; Ericka Wong; Sara C Crystal; Matthew S Robbins; Maria Filopoulos; Richard B Lipton; Yusuf Yazici; Ilya Kister
Journal:  Curr Pain Headache Rep       Date:  2014-09

3.  [Epidemiological, clinical, therapeutic and evolutionary profile of ocular manifestations in patients with Behçet's disease].

Authors:  Amine Razzak; Anass Kassimi; Adil Mchachi; Leila Benhmidoune; Abderrahim Chakib; Rayad Rachid; Mohamed Elbelhadji; Abdelouahed Amraoui; Hassan Elkabli
Journal:  Pan Afr Med J       Date:  2019-06-14

4.  Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behçet's disease: A systematic review of controlled trials.

Authors:  Xinwei Zhou; Xianghui Shi; Yanxia Ren; Tingting Yan; Qiao Ye
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.